Evidence map›Paper›PMID 25884831›Full record

ArticlePloS one2015

Aminotriazole alleviates acetaminophen poisoning via downregulating P450 2E1 and suppressing inflammation.

Yuping Jing, Kunwei Wu, Jiashuo Liu, Qing Ai, Pu Ge, Jie Dai, Rong Jiang, Dan Zhou, Qian Che, Jingyuan Wan and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hepatoprotective Effect of Polysaccharides Isolated fromOxidative medicine and cellular longevity · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yuping JingDepartment of Pathophysiology, Chongqing Medical University, Chongqing, China.
Kunwei WuDepartment of Pathophysiology, Chongqing Medical University, Chongqing, China.
Jiashuo LiuDepartment of Pathophysiology, Chongqing Medical University, Chongqing, China.
Qing AiDepartment of Physiology, Chongqing Medical University, Chongqing, China.
Pu GeDepartment of Pathophysiology, Chongqing Medical University, Chongqing, China.
Jie DaiHospital of Chongqing University of Arts and Sciences, Chongqing, China.
Rong JiangLaboratory of Stem cell and Tissue Engineering, Chongqing Medical University, Chongqing, China.
Dan ZhouDepartment of Pathophysiology, Chongqing Medical University, Chongqing, China.
Qian CheDepartment of Pathophysiology, Chongqing Medical University, Chongqing, China.
Jingyuan WanDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Li ZhangDepartment of Pathophysiology, Chongqing Medical University, Chongqing, China.
Chongqing Medical University · CNChongqing University of Arts and Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aminotriazole (ATZ) is commonly used as a catalase (CAT) inhibitor. We previously found ATZ attenuated oxidative liver injury, but the underlying mechanisms remain unknown. Acetaminophen (APAP) overdose frequently induces life-threatening oxidative hepatitis. In the present study, the potential hepatoprotective effects of ATZ on oxidative liver injury and the underlying mechanisms were further investigated in a mouse model with APAP poisoning. The experimental data indicated that pretreatment with ATZ dose- and time-dependently suppressed the elevation of plasma aminotransferases in APAP exposed mice, these effects were accompanied with alleviated histological abnormality and improved survival rate of APAP-challenged mice. In mice exposed to APAP, ATZ pretreatment decreased the CAT activities, hydrogen peroxide (H2O2) levels, malondialdehyde (MDA) contents, myeloperoxidase (MPO) levels in liver and reduced TNF-α levels in plasma. Pretreatment with ATZ also downregulated APAP-induced cytochrome P450 2E1 (CYP2E1) expression and JNK phosphorylation. In addition, posttreatment with ATZ after APAP challenge decreased the levels of plasma aminotransferases and increased the survival rate of experimental animals. Posttreatment with ATZ had no effects on CYP2E1 expression or JNK phosphorylation, but it significantly decreased the levels of plasma TNF-α. Our data indicated that the LD50 of ATZ in mice was 5367.4 mg/kg body weight, which is much higher than the therapeutic dose of ATZ in the present study. These data suggested that ATZ might be effective and safe in protect mice against APAP-induced hepatotoxicity, the beneficial effects might resulted from downregulation of CYP2E1 and inhibiton of inflammation.

Indexed as

AmitroleAnimalsBody WeightCatalaseChemical and Drug Induced Liver InjuryCytochrome P-450 CYP2E1Down-RegulationHydrogen PeroxideInflammationLethal Dose 50LiverMaleMalondialdehydeMiceMice, Inbred C57BLPeroxidaseAmitroleCatalaseCytochrome P-450 CYP2E1Hydrogen PeroxideMalondialdehydePeroxidaseTransaminasesTumor Necrosis Factor-alpha

Identifiers

PMID25884831
PMCPMC4401561
OpenAlexW2089195675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.